North America to Dominate the Asthma Treatment Market through 2028

Rising prevalence of asthma is expected to drive the growth of global asthma treatment market in the forecast period, 2024-2028.

According to TechSci Research report, “Asthma Treatment Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F”, global asthma treatment market is expected to grow during the forecast period of 2024-2028. This can be ascribed to the increasing awareness of the serious effect of Asthma among the people across the globe.

Global asthma treatment market is being driven by several factors, growing prevalence among people, demands for biologic therapies, and advancement in technologies. Biologic therapies are targeted treatments that address specific underlying mechanisms of asthma and are becoming increasingly popular. This is due to their high efficacy and lower side effect profile compared to traditional asthma medications that are driving the growth of global asthma treatment market. In addition, government initiatives aimed at improving asthma management and reducing healthcare costs are driving demand for effective asthma treatments. It includes initiatives to improve access to healthcare, increase awareness of asthma, and promote research and development in the field.

The United States government has implemented the National Asthma Control Program (NACP), which aims to reduce the burden of asthma through education, research, and access to quality care. Finally, the increasing awareness and the effectiveness of asthma treatment medications are contributing to the growth of the global asthma treatment market. These factors are expected to continue to drive the growth of the global asthma treatment market in the coming years.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on " Asthma Treatment Market"

Global asthma treatment market can be segmented by drug class, mode of administration, distribution channel, and region.

Based on drug type, the global asthma treatment market can be divided into short acting beta-agonists (SABA), long-acting beta-agonists (LABA), inhaled corticosteroids (ICS), leukotriene modifiers, immunomodulators, combination drugs, and others. The inhaled corticosteroids (ICS) segment is expected to dominate the global asthma treatment market in the coming years due to high efficacy of ICS in reducing airway inflammation and improving lung function in individuals with asthma. Combination drugs, which combine two or more medications are popular due to their convenience and effectiveness in managing asthma symptoms. ICS are available in a range of formulations and delivery devices, making them convenient and accessible for patients. They can be delivered via metered-dose inhalers (MDIs), dry powder inhalers (DPIs), or nebulizers, and can be used alone or in combination with other medications. Due to their efficacy and convenience, ICS has a favorable safety profile, with few serious adverse effects when used as directed. This makes them a popular choice for long-term asthma management. Therefore, the inhaled corticosteroids segment is expected to dominate the global asthma treatment market in the coming years.

Based on mode of administration, global asthma treatment market is divided into inhalers, nebulizers, and oral medications. The inhalers segment is expected to dominate the global asthma treatment market in the coming years as inhalers are the most common and convenient way to deliver medication directly to the lungs and are most effective in treating asthma symptoms. They are available in a range of formulations, including inhaled corticosteroids, short-acting beta-agonists, and long-acting beta-agonists, as well as combination drugs, making them a versatile option for asthma management. Inhalers provide quick relief from asthma symptoms such as wheezing, coughing, and shortness of breath. This is particularly important during an asthma attack, where rapid symptom relief can be lifesaving. They are small, portable, and easy to use, making them convenient for use at home, work, or on-the-go. This convenience encourages adherence to treatment regimens, which is important for long-term asthma management. The inhalers are expected to drive the growth of the asthma treatment market across the regions. Therefore, the inhalers are likely to dominate the global asthma treatment market in the coming years.

Major companies operating in global asthma treatment market are:

• GlaxoSmithKline, Plc
• AstraZeneca Plc
• Teva Pharmaceutical Industries Ltd.
• Boehringer Ingelheim Gmbh
• Merck & Co. Inc
• Norvartis AG
• Sanofi SA
• Roche Holding AG
• Regeneron Pharmaceutical Inc.
• Pfizer Inc

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“Global asthma treatment market is rapidly evolving, with significant increasing awareness among different regions. With advances in technology and genetics, there is growing interest in developing personalized medicine approaches for asthma treatment. This involves tailoring treatment regimens to the specific needs and characteristics of each individual patient, which can lead to more effective and efficient treatment. In asthma treatment the dominating Inhalers are available in a wide range of formulations. The market is dominated by inhalers as they are more cost-effective than nebulizers or oral medications, particularly for long-term use. As more consumers become aware of these factors, the market is likely to gain more popularity. Companies are investing in research and development to improve these materials and make them more competitive in the market. Educating patients on proper asthma management techniques and promoting self-management strategies is becoming increasingly important in asthma treatment. This can improve treatment adherence, reduce the risk of exacerbations, and improve overall quality of life for patients with asthma. The increasing partnerships between public and private sectors bodies well for the future of the asthma treatment market, with several medications and improved technologies are to be expected to create lucrative opportunities for the global asthma treatment market growth.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com